Patents by Inventor Maxim Eduardovich Zapolsky

Maxim Eduardovich Zapolsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic derivatives of N,N?-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon
    Patent number: 9440985
    Abstract: The invention relates to novel 3,6,9-triazatricyclo[7.3.1.1]tetradecane-4,8,12-trione derivatives of general formula (1), which act as allosteric AMPA receptor modulators, and to drugs based thereon which can be used for treating Alzheimer's, Parkinson's and other neurodegenerative diseases.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: September 13, 2016
    Inventors: Maxim Eduardovich Zapolsky, Nikolay Serafimovich Zefirov, Vladimir Alexandrovich Palyulin, Mstislav Igorevich Lavrov
  • TRICYCLIC DERIVATIVES OF N,N'-SUBSTITUTED 3,7-DIAZABICYCLO [3.3.1]NONANES AND DRUGS BASED THEREON
    Publication number: 20150274743
    Abstract: The invention relates to novel 3,6,9-triazatricyclo[7.3.1.1]tetradecane-4,8,12-trione derivatives of general formula (1), which act as allosteric AMPA receptor modulators, and to drugs based thereon which can be used for treating Alzheimer's, Parkinson's and other neurodegenerative diseases.
    Type: Application
    Filed: April 2, 2012
    Publication date: October 1, 2015
    Inventors: Maxim Eduardovich Zapolsky, Nikolay Serafimovich Zefirov, Vladimir Alexandrovich Palyulin, Mstislav Igorevich Lavrov
  • COMBINATION FOR THE PROPHYLAXIS AND TREATMENT OF BEHAVIOURAL, MENTAL, AND COGNITIVE DISORDERS
    Publication number: 20150250763
    Abstract: The invention relates to the field of pharmacology and practical medicine, namely, to the combined use of pharmaceutical compositions exhibiting a neurotropic action, alleviating manifestations of mental, behavioral, cognitive disorders in cases of organic damage of various origin to the central nervous system. The combination comprises Memantine and Melatonin in therapeutically efficient quantities. The combination enables to raise disease treatment effectiveness. 1 independent claim, 2 dependent claims. 2 examples, 7 tables.
    Type: Application
    Filed: November 7, 2012
    Publication date: September 10, 2015
    Inventors: Margarita MOROZOVA, Allan Gerovich BENIASHVILI, Maxim Eduardovich ZAPOLSKY
  • Alicyclic derivatives of N,N'-substituted 3,7-diazabicyclo[3.3.1]nonanes and medicaments based thereon
    Patent number: 9067940
    Abstract: The invention relates to novel alicyclic N,N?-substituted diazabicyclo[3.3.1]nonane derivatives of general formula (I) which act as allosteric AMPA receptor modulators, and to drugs based thereon which can be used for treating Alzheimer's, Parkinson's and other neurodegenerative diseases.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: June 30, 2015
    Inventors: Maxim Eduardovich Zapolsky, Nikolay Serafimovich Zefirov, Vladimir Alexandrovich Palyulin, Mstislav Igorevich Lavrov
  • PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF PSYCHOLOGICAL, BEHAVIORAL AND COGNITIVE DISORDERS
    Publication number: 20150157604
    Abstract: The invention relates to the field of medicine and the pharmaceutical-chemical industry, and specifically, the field of neurology, and discloses compositions containing memantine and melatonin. It has been established that a strengthening of the effect of memantine takes place when it is combined with melatonin. The invention may be realized through the preparation of a finished pharmaceutical product such as capsules, preferably hard gelatin capsules.
    Type: Application
    Filed: October 31, 2012
    Publication date: June 11, 2015
    Applicant: LTD << VALENTA-INTELLEKT >>
    Inventors: Margarita Alekseevna Morozova, Allan Gerovich Beniashvili, Maxim Eduardovich Zapolsky
  • PHARMACOLOGICALLY ACTIVE ALICYCLIC N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3.3.1]NONANE DERIVATIVES AND DRUGS BASED THEREON
    Publication number: 20140046067
    Abstract: The invention relates to novel alicyclic N,N?-substituted diazabicyclo[3.3.1]nonane derivatives of general formula (I) which act as allosteric AMPA receptor modulators, and to drugs based thereon which can be used for treating Alzheimer's, Parkinson's and other neurodegenerative diseases.
    Type: Application
    Filed: April 10, 2012
    Publication date: February 13, 2014
    Inventors: Maxim Eduardovich Zapolsky, Nokilai Serafimovich Zefirov, Vladimir Alexandrovich Palyulin, Mstislav Igorevich Lavrov